These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27628669)

  • 1. Transfer from research/academia to clinical/regulated.
    Chowdhury F; Williams A
    Bioanalysis; 2016 Oct; 8(20):2169-76. PubMed ID: 27628669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Starting up and spinning out: The changing nature of partnerships between pharma and academia.
    Yan W
    Nat Med; 2015 Sep; 21(9):968-71. PubMed ID: 26340114
    [No Abstract]   [Full Text] [Related]  

  • 4. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry.
    Stahel RA; Lacombe D; Cardoso F; Casali PG; Negrouk A; Marais R; Hiltbrunner A; Vyas M;
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32213534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An industry perspective on tiered approach to the investigation of metabolites in drug development.
    Huskey SE; Li W; Mangold JB; Flarakos J
    Bioanalysis; 2014 Mar; 6(5):617-28. PubMed ID: 24620804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 20th International Reid Bioanalytical Forum.
    Houghton R
    Bioanalysis; 2014 Jan; 6(2):121-6. PubMed ID: 24423590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expectation for the drug development activity in academia].
    Inagaki O
    Yakugaku Zasshi; 2013; 133(2):213-9. PubMed ID: 23370516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to set up collaborations between academia and industrial biotech companies.
    Pronk JT; Lee SY; Lievense J; Pierce J; Palsson B; Uhlen M; Nielsen J
    Nat Biotechnol; 2015 Mar; 33(3):237-40. PubMed ID: 25748909
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical industry, academia and patient advocacy organizations: what is the recipe for synergic (win-win-win) collaborations?
    Rose DM; Marshall R; Surber MW
    Respirology; 2015 Feb; 20(2):185-91. PubMed ID: 25580960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating internal and external bioanalytical support to deliver a diversified pharmaceutical portfolio.
    Summerfield SG; Evans C; Spooner N; Dunn JA; Szapacs ME; Yang E
    Bioanalysis; 2014 May; 6(10):1311-9. PubMed ID: 24958115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface.
    Andrews DM; Swarbrick ME; Merritt AT
    Drug Discov Today; 2014 Apr; 19(4):496-501. PubMed ID: 24486295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of outsourced preclinical research--the example of chemical synthesis.
    Festel GW
    Expert Opin Drug Discov; 2013 Sep; 8(9):1049-55. PubMed ID: 23725522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating technology transfer: new relationships for academia, industry and government.
    Satava RM
    Stud Health Technol Inform; 1998; 50():1-6. PubMed ID: 10180523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partnership between small biotech and big pharma.
    Wiederrecht GJ; Hill RG; Beer MS
    IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are multimetabolite methods fit-for-purpose for supporting toxicology studies?
    Smith G
    Bioanalysis; 2011 Dec; 3(24):2701-4. PubMed ID: 22185267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.